Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mei Sheng Duh

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Krishnan S, Sarda S, Kunzweiler C, Wu M, Sundaresan S, Huynh L, Duh MS, Escalante CP. Literature Review of Fatigue Scales and Association with Clinically Meaningful Improvements in Outcomes Among Patients With and Without Paroxysmal Nocturnal Hemoglobinuria. Adv Ther. 2022 Mar 22. PMID: 35316499.
    Citations:    Fields:    
  2. Mannino D, Bogart M, Germain G, Huang SP, Ismaila AS, Laliberté F, Jung Y, MacKnight SD, Stiegler MA, Duh MS. Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. Int J Chron Obstruct Pulmon Dis. 2022; 17:491-504. PMID: 35281476.
    Citations:    Fields:    
  3. Choi NK, Shantakumar S, Kim MS, Lee CH, Cheng WY, Bobbili P, Yang BR, Lee J, Hinds D, Duh MS, Korves C, Park HW. Real-world Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Newly Treated Korean Patients With Asthma: A Retrospective Cohort Study. Allergy Asthma Immunol Res. 2022 Mar; 14(2):220-232. PMID: 35255539.
    Citations:    
  4. Cheng WY, Avery RK, Thompson-Leduc P, Cheung HC, Bo T, Duh MS, Hirji I. Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation. J Med Econ. 2022 Jan-Dec; 25(1):367-380. PMID: 35240904.
    Citations:    Fields:    
  5. Lulic Z, Son H, Yoo SB, Cunnington M, Kapse P, Miller D, Cortes V, Park S, Bhak RH, Duh MS. Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database. BMC Urol. 2021 Dec 21; 21(1):178. PMID: 34933674.
    Citations:    Fields:    Translation:Humans
  6. Ghaswalla P, Thompson-Leduc P, Cheng WY, Kunzweiler C, Wang MJ, Bogart M, Patterson BJ, Duh MS, Wojciehowski J, Park S, Yawn BP. Increased Health Care Resource Utilization and Costs Associated with Herpes Zoster Among Patients Aged =50 Years with Chronic Obstructive Pulmonary Disease in the United States. Chronic Obstr Pulm Dis. 2021 Oct 28; 8(4):502-516. PMID: 34614552.
    Citations: 1     
  7. Arondekar B, Duh MS, Bhak RH, DerSarkissian M, Huynh L, Wang K, Wojciehowski J, Wu M, Wornson B, Niyazov A, Demetri GD. Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020. Clin Cancer Res. 2022 01 01; 28(1):27-35. PMID: 34667027.
    Citations:    Fields:    
  8. Patel AK, Abhyankar R, Brais LK, Duh MS, Barghout VE, Huynh L, Yenikomshian MA, Ng K, Fuchs CS. Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology Center. Oncologist. 2021 12; 26(12):e2161-e2169. PMID: 34406678.
    Citations:    Fields:    Translation:Humans
  9. Bhak RH, Mody-Patel N, Baver SB, Kunzweiler C, Yee CW, Sundaresan S, Swartz N, Duh MS, Krishnan S, Sarda SP. Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison. Curr Med Res Opin. 2021 11; 37(11):1913-1923. PMID: 34445916.
    Citations: 2     Fields:    Translation:Humans
  10. Averell CM, Laliberté F, Germain G, Duh MS, Lima R, Mahendran M, Slade DJ. Symptom control in patients with asthma using inhaled corticosteroids/long-acting ß2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study. J Asthma. 2021 Aug 25; 1-14. PMID: 34375568.
    Citations:    Fields:    
  11. Lin D, Laliberté F, Majeski C, Magestro M, Lejeune D, Duh MS, Lim-Watson M, Paolini JF. Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population. Adv Ther. 2021 10; 38(10):5127-5143. PMID: 34417724.
    Citations:    Fields:    Translation:Humans
  12. Averell CM, Laliberté F, Germain G, Slade DJ, Duh MS, Spahn J. Disease burden and treatment adherence among children and adolescent patients with asthma. J Asthma. 2021 Aug 04; 1-10. PMID: 34346263.
    Citations: 1     Fields:    
  13. Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, Mahendran M, Hahn B. Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study. BMC Pulm Med. 2021 Jul 31; 21(1):253. PMID: 34332555.
    Citations:    Fields:    Translation:Humans
  14. Shore ND, Laliberté F, Ionescu-Ittu R, Yang L, Mahendran M, Lejeune D, Yu LH, Burgents J, Duh MS, Ghate SR. Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors. Adv Ther. 2021 08; 38(8):4520-4540. PMID: 34282527.
    Citations:    Fields:    Translation:Humans
  15. Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Mahendran M, Lejeune D, Yu LH, Duh MS. Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population. Adv Ther. 2021 08; 38(8):4461-4479. PMID: 34275086.
    Citations:    Fields:    Translation:Humans
  16. Yu KH, Hendifar AE, Alese OB, Draper A, Abdelrahim M, Burns E, Khan G, Cockrum P, Bhak RH, Nguyen C, DerSarkissian M, Duh MS, Bahary N. Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan. Front Oncol. 2021; 11:678070. PMID: 34336666.
    Citations:    
  17. Shore ND, Ionescu-Ittu R, Laliberté F, Yang L, Lejeune D, Yu L, Duh MS, Mahendran M, Kim J, Ghate SR. Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study. Clin Genitourin Cancer. 2021 12; 19(6):480-490. PMID: 34373223.
    Citations:    Fields:    Translation:Humans
  18. Sheikhan NY, Pinto AM, Nowak DA, Abolhassani F, Lefebvre P, Duh MS, Witek TJ. Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms. JAMA Netw Open. 2021 07 01; 4(7):e2116551. PMID: 34251442.
    Citations: 2     Fields:    Translation:Humans
  19. Mapel DW, Roberts MH, Sama S, Bobbili PJ, Cheng WY, Duh MS, Nguyen C, Thompson-Leduc P, Van Dyke MK, Rothnie KJ, Sundaresan D, Certa JM, Whiting TS, Brown JL, Roblin DW. Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2021; 16:1687-1698. PMID: 34135580.
    Citations:    Fields:    Translation:Humans
  20. Shore N, Ionescu-Ittu R, Yang L, Laliberté F, Mahendran M, Lejeune D, Yu L, Burgents J, Duh MS, Ghate SR. Real-world genetic testing patterns in metastatic castration-resistant prostate cancer. Future Oncol. 2021 Aug; 17(22):2907-2921. PMID: 33906368.
    Citations:    Fields:    Translation:HumansCells
  21. Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B. Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities. Int J Chron Obstruct Pulmon Dis. 2021; 16:1149-1161. PMID: 33911860.
    Citations: 1     Fields:    Translation:Humans
  22. Laliberté F, Duh MS, Barghout V, Germain G, Frech F, Plauschinat C, Lejeune D, Malhotra M, Faught E. Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States. Epilepsy Behav. 2021 05; 118:107927. PMID: 33812233.
    Citations:    Fields:    Translation:Humans
  23. Wells JC, Dudani S, Gan CL, Stukalin I, Azad AA, Liow E, Donskov F, Yuasa T, Pal SK, De Velasco G, Hansen AR, Beuselinck B, Kollmannsberger CK, Powles T, McGregor BA, Duh MS, Huynh L, Heng DYC. Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study. Clin Genitourin Cancer. 2021 08; 19(4):354-361. PMID: 33863648.
    Citations:    Fields:    Translation:Humans
  24. Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B. Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease. Pulm Ther. 2021 Jun; 7(1):203-219. PMID: 33728597.
    Citations: 1     
  25. Yang X, Laliberté F, Germain G, Raut M, Duh MS, Sen SS, Lejeune D, Desai K, Armand P. Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S. Oncologist. 2021 05; 26(5):e817-e826. PMID: 33616256.
    Citations: 1     Fields:    Translation:Humans
  26. Laliberté F, Raut M, Yang X, Germain G, Nahar A, Desai KD, MacKnight SD, Sen SS, Duh MS. Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA. Target Oncol. 2021 01; 16(1):85-94. PMID: 33284424.
    Citations:    Fields:    Translation:Humans
  27. Yang X, Laliberté F, Germain G, Raut M, Duh MS, Sen SS, Lejeune D, Desai K, Armand P. Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States. J Med Econ. 2021 Jan-Dec; 24(1):469-478. PMID: 33784916.
    Citations:    Fields:    Translation:Humans
  28. Priest J, Bhak RH, Dersarkissian M, Oglesby A, Kunzweiler C, Fuqua E, Park S, Duh MS, Garris C. Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population. J Med Econ. 2021 Jan-Dec; 24(1):1204-1211. PMID: 34665994.
    Citations:    Fields:    Translation:Humans
  29. Gounder MM, Merriam P, Ratan R, Patel SR, Chugh R, Villalobos VM, Thornton M, Van Tine BA, Abdelhamid AH, Whalen J, Yang J, Rajarethinam A, Duh MS, Bobbili PJ, Huynh L, Totev TI, Lax AK, Agarwal S, Demetri GD. Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer. 2021 04 15; 127(8):1311-1317. PMID: 33296083.
    Citations: 2     Fields:    Translation:Humans
  30. LeWinter M, Kontzias A, Lin D, Cella D, DerSarkissian M, Zhou M, Duh MS, Lim-Watson M, Magestro M. Burden of Recurrent Pericarditis on Health-Related Quality of Life. Am J Cardiol. 2021 02 15; 141:113-119. PMID: 33220316.
    Citations: 4     Fields:    Translation:Humans
  31. Chung ES, Rickard J, Lu X, DerSarkissian M, Zichlin ML, Cheung HC, Swartz N, Greatsinger A, Duh MS. Real-World Economic Burden Among Patients With And Without Heart Failure Worsening After Cardiac Resynchronization Therapy. Adv Ther. 2021 01; 38(1):441-467. PMID: 33141415.
    Citations:    Fields:    Translation:Humans
  32. Metz DC, Liu E, Joish VN, Huynh L, Totev TI, Duh MS, Seth K, Giacalone S, Lapuerta P, Morse MA. Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome. Cancer Manag Res. 2020; 12:9713-9719. PMID: 33116830.
    Citations:    
  33. McKay RR, Silver R, Bhak RH, Korves C, Cheng M, Appukkuttan S, Simmons SJ, Duh MS, Taplin ME. Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center. Prostate Cancer Prostatic Dis. 2021 03; 24(1):210-219. PMID: 32814846.
    Citations: 1     Fields:    Translation:Humans
  34. Morse MA, Liu E, Joish VN, Huynh L, Cheng M, Duh MS, Seth K, Lapuerta P, Metz DC. Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study. Cancer Manag Res. 2020; 12:6607-6614. PMID: 32801896.
    Citations: 1     
  35. Eichenfield LF, DiBonaventura M, Xenakis J, Lafeuille MH, Duh MS, Fakih I, Levenberg M, Cappelleri JC, Sikirica V. Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database. Dermatol Ther (Heidelb). 2020 Aug; 10(4):791-806. PMID: 32607738.
    Citations: 3     
  36. Bobbili P, Olufade T, DerSarkissian M, Shenolikar R, Yu H, Duh MS, Tung N. Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study. Hered Cancer Clin Pract. 2020; 18:13. PMID: 32518611.
    Citations:    
  37. Chiang AC, Fernandes AW, Pavilack M, Wu JW, Laliberté F, Duh MS, Chehab N, Subramanian J. EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors. BMC Cancer. 2020 Apr 28; 20(1):356. PMID: 32345265.
    Citations: 7     Fields:    Translation:Humans
  38. Bobbili P, Ryan K, DerSarkissian M, Dua A, Yee C, Duh MS, Gomez JE. Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer. PLoS One. 2020; 15(3):e0230444. PMID: 32187231.
    Citations: 1     Fields:    Translation:Humans
  39. Peffault de Latour R, Huynh L, Ivanova JI, Totev T, Bilginsoy M, Antin J, Roy A, Duh MS. Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study. Ann Hematol. 2020 Apr; 99(4):743-752. PMID: 32065291.
    Citations:    Fields:    Translation:Humans
  40. Pepose JS, Sarda SP, Cheng WY, McCormick N, Cheung HC, Bobbili P, Joseph C, Duh MS. Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States. Clin Ophthalmol. 2020; 14:377-387. PMID: 32103884.
    Citations: 1     
  41. Ramasamy A, Laliberté F, Aktavoukian SA, Lejeune D, DerSarkissian M, Cavanaugh C, Smolarz BG, Ganguly R, Duh MS. Direct, Absenteeism, and Disability Cost Burden of Obesity Among Privately Insured Employees: A Comparison of Healthcare Industry Versus Other Major Industries in the United States. J Occup Environ Med. 2020 02; 62(2):98-107. PMID: 31714373.
    Citations:    Fields:    Translation:Humans
  42. DerSarkissian M, Bhak RH, Oglesby A, Priest J, Gao E, Macheca M, Sharperson C, Duh MS. Retrospective analysis of comorbidities and treatment burden among patients with HIV infection in a US Medicaid population. Curr Med Res Opin. 2020 05; 36(5):781-788. PMID: 31944138.
    Citations: 1     Fields:    Translation:Humans
  43. Savard MF, Wells JC, Graham J, Dudani S, Steinharter JA, McGregor BA, Donskov F, Bjarnason GA, Vaishampayan UN, Hansen AR, Iafolla MAJ, Zanotti G, Huynh L, Chang R, Duh MS, Heng DYC. Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group. Oncologist. 2020 05; 25(5):422-430. PMID: 31971318.
    Citations: 3     Fields:    Translation:Humans
  44. Siffel C, DerSarkissian M, Kponee-Shovein K, Spalding W, Gu YM, Cheng M, Duh MS. Suicidal ideation and attempts in the United States of America among stimulant-treated, non-stimulant-treated, and untreated patients with a diagnosis of attention-deficit/hyperactivity disorder. J Affect Disord. 2020 04 01; 266:109-119. PMID: 32063553.
    Citations: 2     Fields:    Translation:Humans
  45. Wells JC, Graham J, Beuselinck B, Bjarnason GA, Donskov F, Hansen AR, McKay RR, Vaishampayan U, De Velasco G, Duh MS, Huynh L, Nguyen C, Zanotti G, Ramaswamy K, Choueiri TK, Heng DYC. Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2020 08; 18(4):e350-e359. PMID: 31926879.
    Citations: 1     Fields:    Translation:Humans
  46. Graham J, Shah AY, Wells JC, McKay RR, Vaishampayan U, Hansen A, Donskov F, Bjarnason GA, Beuselinck B, De Velasco G, Iafolla M, Duh MS, Huynh L, Chang R, Zanotti G, Ramaswamy K, Choueiri TK, Tannir NM, Heng DYC. Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors. Eur Urol Oncol. 2021 02; 4(1):102-111. PMID: 31786162.
    Citations: 5     Fields:    Translation:Humans
  47. Wysham CH, Gauthier-Loiselle M, Bailey RA, Manceur AM, Lefebvre P, Greenberg M, Duh MS, Young JB. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study. Curr Med Res Opin. 2020 02; 36(2):219-227. PMID: 31625766.
    Citations: 2     Fields:    Translation:Humans
  48. Ramasamy A, Laliberté F, Aktavoukian SA, Lejeune D, DerSarkissian M, Cavanaugh C, Smolarz BG, Ganguly R, Duh MS. Direct and Indirect Cost of Obesity Among the Privately Insured in the United States: A Focus on the Impact by Type of Industry. J Occup Environ Med. 2019 11; 61(11):877-886. PMID: 31425324.
    Citations: 1     Fields:    Translation:Humans
  49. Averell CM, Stanford RH, Laliberté F, Wu JW, Germain G, Duh MS. Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs. J Asthma. 2021 01; 58(1):102-111. PMID: 31607180.
    Citations: 9     Fields:    Translation:Humans
  50. Grivas P, DerSarkissian M, Shenolikar R, Laliberté F, Doleh Y, Duh MS. Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA. Future Oncol. 2019 Nov; 15(33):3809-3818. PMID: 31596144.
    Citations: 3     Fields:    Translation:Humans
  51. Patel AK, Barghout V, Yenikomshian MA, Germain G, Jacques P, Laliberté F, Duh MS. Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib. Oncologist. 2020 01; 25(1):e75-e84. PMID: 31591140.
    Citations: 2     Fields:    Translation:Humans
  52. Averell CM, Laliberté F, Duh MS, Wu JW, Germain G, Faison S. Characterizing Real-World Use Of Tiotropium In Asthma In The USA. J Asthma Allergy. 2019; 12:309-321. PMID: 31632091.
    Citations: 4     
  53. Shah BR, DerSarkissian M, Tsintzos SI, Xiao Y, May D, Lu X, Kinrich D, Davis E, Lefebvre P, Duh MS, Dasta JF. Adherence to heart failure management medications following cardiac resynchronization therapy. Curr Med Res Opin. 2020 02; 36(2):199-207. PMID: 31535559.
    Citations: 2     Fields:    Translation:Humans
  54. Huynh L, Cai B, Cheng M, Lax A, Lejeune D, Duh MS, Kim MK. Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors. Pancreas. 2019 10; 48(9):1126-1135. PMID: 31593022.
    Citations: 2     Fields:    Translation:Humans
  55. Bobbili P, Ryan K, Duh MS, Dua A, Fernandes AW, Pavilack M, Gomez JE. Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer. Future Oncol. 2019 Oct; 15(29):3381-3393. PMID: 31544510.
    Citations: 7     Fields:    Translation:Humans
  56. Cheng WY, Chang R, Novy P, O'Connor C, Duh MS, Hogea CS. Determinants of Meningococcal ACWY vaccination in adolescents in the US: completion and compliance with the CDC recommendations. Hum Vaccin Immunother. 2020; 16(1):176-188. PMID: 31419168.
    Citations:    Fields:    Translation:HumansPHPublic Health
  57. Subramanian J, Fernandes AW, Laliberté F, Pavilack M, DerSarkissian M, Duh MS. The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors. Lung Cancer. 2019 12; 138:131-138. PMID: 31733614.
    Citations: 1     Fields:    Translation:Humans
  58. Ghate S, Ionescu-Ittu R, Burne R, Ndife B, Laliberté F, Nakasato A, Duh MS. Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive. Melanoma Res. 2019 06; 29(3):301-310. PMID: 30247203.
    Citations: 2     Fields:    Translation:Humans
  59. Vekeman F, Piña-Garza JE, Cheng WY, Tuttle E, Giguère-Duval P, Oganisian A, Damron J, Sheng Duh M, Shen V, Saurer TB, Montouris GD, Isojarvi J. Development of a classifier to identify patients with probable Lennox-Gastaut syndrome in health insurance claims databases via random forest methodology. Curr Med Res Opin. 2019 08; 35(8):1415-1420. PMID: 30870597.
    Citations:    Fields:    Translation:Humans
  60. Halperin DM, Huynh L, Beaumont JL, Cai B, Bhak RH, Narkhede S, Totev T, Duh MS, Neary MP, Cella D. Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome. BMC Cancer. 2019 Mar 28; 19(1):274. PMID: 30922252.
    Citations: 4     Fields:    Translation:Humans
  61. Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019; 14:343-352. PMID: 30863037.
    Citations: 18     Fields:    Translation:Humans
  62. Ailawadhi S, DerSarkissian M, Duh MS, Lafeuille MH, Posner G, Ralston S, Zagadailov E, Ba-Mancini A, Rifkin R. Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma. Clin Ther. 2019 03; 41(3):477-493.e7. PMID: 30773308.
    Citations: 2     Fields:    Translation:Humans
  63. Taher AT, Origa R, Perrotta S, Kouraklis A, Belhoul K, Huang V, Han J, Bruederle A, Bobbili P, Duh MS, Porter JB. Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis. Am J Hematol. 2019 04; 94(4):E96-E99. PMID: 30663129.
    Citations:    Fields:    Translation:Humans
  64. Appukkuttan S, Duchesneau E, Zichlin ML, Bhak RH, Yaldo A, Gharibo M, Babajanyan S, Duh MS. A Budget Impact Analysis of the Introduction of Copanlisib for Treatment of Relapsed Follicular Lymphoma in the United States. J Manag Care Spec Pharm. 2019 Jan 04; 1-12. PMID: 30608008.
    Citations: 3     Fields:    
  65. Dasari A, Bergsland EK, Benson AB, Cai B, Huynh L, Totev T, Shea J, Duh MS, Neary MP, Dagohoy CG, Shih BE, Maurer VE, Chan J, Kulke MH. Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study. Oncologist. 2019 08; 24(8):1066-1075. PMID: 30610008.
    Citations: 4     Fields:    Translation:Humans
  66. Kulke MH, Benson AB, Dasari A, Huynh L, Cai B, Totev T, Roesner N, Duh MS, Neary MP, Maurer VE, Shih BE, Dagohoy CG, Chan J, Bergsland EK. Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study. Oncologist. 2019 08; 24(8):1056-1065. PMID: 30606883.
    Citations: 1     Fields:    Translation:Humans
  67. Tarhini A, Ghate SR, Ionescu-Ittu R, Manceur AM, Ndife B, Jacques P, Laliberté F, Nakasato A, Burne R, Duh MS. Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma. Melanoma Res. 2018 12; 28(6):618-628. PMID: 30216199.
    Citations: 4     Fields:    Translation:Humans
  68. Khelif A, Saleh MN, Salama A, Portella MDSO, Duh MS, Ivanova J, Grotzinger K, Roy AN, Bussel JB. Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study. Am J Hematol. 2019 02; 94(2):200-208. PMID: 30417939.
    Citations: 9     Fields:    Translation:HumansCells
  69. Zonnenberg BA, Neary MP, Duh MS, Ionescu-Ittu R, Fortier J, Vekeman F. Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus. PLoS One. 2018; 13(11):e0204646. PMID: 30439947.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  70. Laliberté F, Dea K, Duh MS, Kahler KH, Rolli M, Lefebvre P. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause. 2018 11; 25(11):1297-1305. PMID: 30358726.
    Citations: 6     Fields:    Translation:Humans
  71. Halperin DM, Huynh L, Beaumont JL, Cai B, Totev T, Bhak RH, Duh MS, Neary MP, Cella D. Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study. Medicine (Baltimore). 2018 Nov; 97(47):e13390. PMID: 30461659.
    Citations: 2     Fields:    Translation:Humans
  72. Wysham CH, Lefebvre P, Pilon D, Lafeuille MH, Emond B, Kamstra R, Pfeifer M, Duh MS, Ingham M. An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records. J Diabetes Complications. 2019 02; 33(2):140-147. PMID: 30554838.
    Citations: 2     Fields:    Translation:Humans
  73. Ortega H, Llanos JP, Lafeuille MH, Duh MS, Germain G, Lejeune D, Sama S, Bell C, Hahn B. Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data. J Asthma. 2019 Aug; 56(8):808-815. PMID: 30130418.
    Citations: 8     Fields:    Translation:HumansCells
  74. Tarhini A, Ghate S, Ionescu-Ittu R, Shi S, Nakasato A, Ndife B, Laliberté F, Burne R, Duh MS. Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study. Future Oncol. 2019 Feb; 15(4):359-370. PMID: 30317881.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  75. Llanos JP, Ortega H, Germain G, Duh MS, Lafeuille MH, Tiggelaar S, Bell CF, Hahn B. Health characteristics of patients with asthma, COPD and asthma-COPD overlap in the NHANES database. Int J Chron Obstruct Pulmon Dis. 2018; 13:2859-2868. PMID: 30254433.
    Citations: 5     Fields:    Translation:Humans
  76. Oh WK, Cheng WY, Miao R, Vekeman F, Gauthier-Loiselle M, Duh MS, Drea E, Szatrowski TP. Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting. Urol Oncol. 2018 11; 36(11):500.e1-500.e9. PMID: 30201382.
    Citations: 10     Fields:    Translation:Humans
  77. Vekeman F, Weiss L, Aram J, Ionescu-Ittu R, Moosavi S, Xiao Y, Cheng WY, Bhak RH, Tawadrous M, Capparella MR, Montravers P, Duh MS. Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication. BMC Infect Dis. 2018 Aug 29; 18(1):438. PMID: 30157797.
    Citations: 1     Fields:    Translation:Humans
  78. Young JB, Gauthier-Loiselle M, Bailey RA, Manceur AM, Lefebvre P, Greenberg M, Lafeuille MH, Duh MS, Bookhart B, Wysham CH. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data. Cardiovasc Diabetol. 2018 08 24; 17(1):118. PMID: 30143045.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  79. Ortega H, Llanos JP, Lafeuille MH, Germain G, Duh MS, Bell CF, Sama SR, Hahn B. Burden of disease associated with a COPD eosinophilic phenotype. Int J Chron Obstruct Pulmon Dis. 2018; 13:2425-2433. PMID: 30147308.
    Citations: 11     Fields:    Translation:HumansCells
  80. Ghate SR, Ionescu-Ittu R, Burne R, Ndife B, Laliberté F, Nakasato A, Duh MS. Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib?+?trametinib versus nivolumab or pembrolizumab monotherapy. Curr Med Res Opin. 2018 12; 34(12):2169-2176. PMID: 30009647.
    Citations: 1     Fields:    Translation:Humans
  81. Ghaswalla PK, Patterson BJ, Cheng WY, Duchesneau E, Macheca M, Duh MS. Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis. Hum Vaccin Immunother. 2018; 14(11):2780-2785. PMID: 29923789.
    Citations: 5     Fields:    
  82. Kallenbach L, Shui AM, Cheng WY, Fan T, Hu W, Zichlin ML, Duh MS, Ye F, Levin PA. Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting. Endocr Pract. 2018 09; 24(9):805-814. PMID: 29975575.
    Citations: 3     Fields:    Translation:Humans
  83. Slater J, Chung S, Huynh L, Duh MS, Gorin B, McMicken C, Ziemann A, Isojarvi J. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials. Epilepsy Res. 2018 07; 143:120-129. PMID: 29784458.
    Citations: 3     Fields:    Translation:Humans
  84. Cheng WY, Said Q, Hao Y, Xiao Y, Vekeman F, Bobbili P, Duh MS, Nandal S, Blinder M. Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets. Curr Med Res Opin. 2018 11; 34(11):1959-1966. PMID: 29701080.
    Citations: 1     Fields:    Translation:Humans
  85. Walker AM, Schneeweiss S, DerSarkissian M, Duh MS. Removal of ineligible outcome cases reduces confounding. Clin Epidemiol. 2018; 10:575-579. PMID: 29872346.
    Citations:    
  86. Patel AK, Duh MS, Barghout V, Yenikomshian MA, Xiao Y, Wynant W, Tabesh M, Fuchs CS. Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib. Clin Colorectal Cancer. 2018 09; 17(3):e531-e539. PMID: 29803544.
    Citations: 4     Fields:    Translation:Humans
  87. Tanton D, Duh MS, Lafeuille MH, Lefebvre P, Pilon D, Zhdanava M, Emond B, Inman D, Bailey RA. Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida. Curr Med Res Opin. 2018 06; 34(6):1099-1115. PMID: 29468896.
    Citations: 1     Fields:    Translation:Humans
  88. Pickard AS, Huynh L, Ivanova JI, Totev T, Graham S, Mühlbacher AC, Roy A, Duh MS. Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment. J Patient Rep Outcomes. 2017; 2(1):13. PMID: 29757294.
    Citations: 2     
  89. Jabbour E, DerSarkissian M, Duh MS, McCormick N, Cheng WY, McGarry LJ, Souroutzidis A, Huang H, O'Brien S, Ravandi F, Kantarjian HM. Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2018 04; 18(4):257-265. PMID: 29519619.
    Citations: 16     Fields:    Translation:HumansCells
  90. Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Schatz M, Vekeman F, Gauthier-Loiselle M, Merrigan JFP, Duh MS. Claims-based risk model for first severe COPD exacerbation. Am J Manag Care. 2018 02 01; 24(2):e45-e53. PMID: 29461849.
    Citations: 7     Fields:    Translation:Humans
  91. Ruud Bosch JLH, Vekeman F, Duh MS, Neary M, Magestro M, Fortier J, Karner P, Ionescu-Ittu R, Zonnenberg BA. Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center. Int Urol Nephrol. 2018 Mar; 50(3):459-467. PMID: 29333579.
    Citations: 1     Fields:    Translation:Humans
  92. Yan S, DerSarkissian M, Bhak RH, Lefebvre P, Duh MS, Krishnarajah G. Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis. Curr Med Res Opin. 2018 07; 34(7):1261-1269. PMID: 29231748.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  93. Ivanova JI, Saverno KR, Sung J, Duh MS, Zhao C, Cai S, Vekeman F, Peevyhouse A, Dhawan R, Fuchs CS. Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA. Med Oncol. 2017 Nov 04; 34(12):193. PMID: 29103187.
    Citations: 12     Fields:    Translation:Humans
  94. Oh WK, Miao R, Vekeman F, Sung J, Cheng WY, Gauthier-Loiselle M, Dhawan R, Duh MS. Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting. Med Oncol. 2017 Aug 10; 34(9):160. PMID: 28795333.
    Citations: 4     Fields:    Translation:Humans
  95. Krishnarajah G, Kageleiry A, Korves C, Lefebvre P, Duh MS. Public health impact of Rotarix vaccination among commercially insured children in the United States. Vaccine. 2017 09 05; 35(37):5065-5072. PMID: 28778611.
    Citations:    Fields:    Translation:HumansPHPublic Health
  96. Faught E, Laliberté F, Wang Z, Barghout V, Haider B, Lejeune D, Germain G, Choi J, Wagh A, Duh MS. Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States. Epilepsia. 2017 10; 58(10):1742-1748. PMID: 28741690.
    Citations: 2     Fields:    Translation:Humans
  97. Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy. Int J Chron Obstruct Pulmon Dis. 2017; 12:1825-1836. PMID: 28684905.
    Citations: 5     Fields:    Translation:Humans
  98. Lefebvre P, Muser E, Joshi K, DerSarkissian M, Bhak RH, Duh MS, Shiner B, Young-Xu Y. Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse. Clin Ther. 2017 Jul; 39(7):1380-1395.e4. PMID: 28641996.
    Citations: 5     Fields:    Translation:Humans
  99. Huynh L, Totev T, Vekeman F, Neary MP, Duh MS, Benson AB. Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR. J Med Econ. 2017 Sep; 20(9):945-951. PMID: 28562131.
    Citations: 3     Fields:    Translation:Humans
  100. Oh WK, Miao R, Vekeman F, Sung J, Cheng WY, Gauthier-Loiselle M, Dhawan R, Duh MS. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting. Clin Genitourin Cancer. 2017 Jun 19. PMID: 28729067.
    Citations: 9     Fields:    
  101. Piña-Garza JE, Montouris GD, Vekeman F, Cheng WY, Tuttle E, Giguere-Duval P, Duh MS, Shen V, Saurer TB, Isojarvi J. Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome. Epilepsy Behav. 2017 08; 73:46-50. PMID: 28609734.
    Citations: 6     Fields:    Translation:Humans
  102. Wysham CH, Lefebvre P, Pilon D, Ingham M, Lafeuille MH, Emond B, Kamstra R, Chow W, Pfeifer M, Duh MS. Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors. BMC Endocr Disord. 2017 Jun 08; 17(1):32. PMID: 28595617.
    Citations:    Fields:    Translation:Humans
  103. Herring M, Huynh L, Duh MS, Vekeman F, Tiew A, Neary M, Bergsland E. Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practices. Med Oncol. 2017 May; 34(5):88. PMID: 28393314.
    Citations: 3     Fields:    Translation:Humans
  104. Nicolini FE, Basak GW, Kim DW, Olavarria E, Pinilla-Ibarz J, Apperley JF, Hughes T, Niederwieser D, Mauro MJ, Chuah C, Hochhaus A, Martinelli G, DerSarkissian M, Duh MS, McGarry LJ, Kantarjian HM, Cortes JE. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation. Cancer. 2017 Aug 01; 123(15):2875-2880. PMID: 28387926.
    Citations: 29     Fields:    Translation:HumansCells
  105. DerSarkissian M, Bhak RH, Huang J, Buchs S, Vekeman F, Smolarz BG, Brett J, Ganguly R, Duh MS. Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population. Curr Med Res Opin. 2017 06; 33(6):1105-1110. PMID: 28294635.
    Citations: 5     Fields:    Translation:Humans
  106. Skarbnik AP, Ma E, Lafeuille MH, Fortier J, Feldman T, Duh MS, van de Velde H, Niculescu L, Bonthapally V, Goy A. Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices. Leuk Lymphoma. 2017 08; 58(8):1968-1972. PMID: 28092998.
    Citations:    Fields:    Translation:Humans
  107. Kageleiry A, Samuelson D, Duh MS, Lefebvre P, Campbell J, Skotko BG. Out-of-pocket medical costs and third-party healthcare costs for children with Down syndrome. Am J Med Genet A. 2017 Mar; 173(3):627-637. PMID: 27966292.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  108. Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Dalal AA. Burden of systemic glucocorticoid-related complications in severe asthma. Curr Med Res Opin. 2017 01; 33(1):57-65. PMID: 27627132.
    Citations: 17     Fields:    Translation:Humans
  109. Young-Xu Y, Duh MS, Muser E, DerSarkissian M, Faust E, Kageleiry A, Bhak RH, Fu DJ, Lefebvre P, Shiner B. Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia. J Clin Psychiatry. 2016 Oct; 77(10):e1332-e1341. PMID: 27574835.
    Citations: 5     Fields:    Translation:Humans
  110. Lafeuille MH, Frois C, Cloutier M, Duh MS, Lefebvre P, Pesa J, Clancy Z, Fastenau J, Durkin M. Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia. Am Health Drug Benefits. 2016 Oct; 9(7):399-410. PMID: 27994714.
    Citations: 2     
  111. DerSarkissian M, Xiao Y, Duh MS, Lefebvre P, Swensen AR, Bell CF. Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States. J Manag Care Spec Pharm. 2016 Oct; 22(10):1204-14. PMID: 27668569.
    Citations: 1     Fields:    Translation:Humans
  112. Duh MS, Cremieux P, Audenrode MV, Vekeman F, Karner P, Zhang H, Greenberg P. Can social media data lead to earlier detection of drug-related adverse events? Pharmacoepidemiol Drug Saf. 2016 12; 25(12):1425-1433. PMID: 27601271.
    Citations: 16     Fields:    Translation:Humans
  113. Law A, Pilon D, Lynen R, Laliberté F, Gozalo L, Lefebvre P, Duh MS. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population. Reprod Health. 2016 Aug 22; 13(1):96. PMID: 27549429.
    Citations: 1     Fields:    Translation:Humans
  114. Ma E, Bonthapally V, Chawla A, Lefebvre P, Swords R, Lafeuille MH, Fortier J, Emond B, Duh MS, Dezube BJ. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices. Clin Lymphoma Myeloma Leuk. 2016 11; 16(11):625-636.e3. PMID: 27686689.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  115. Dalal AA, Duh MS, Gozalo L, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Lefebvre P. Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma. J Manag Care Spec Pharm. 2016 Jul; 22(7):833-47. PMID: 27348284.
    Citations: 22     Fields:    Translation:Humans
  116. Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Vekeman F, Gauthier-Loiselle M, Duh MS, Merrigan JF, Schatz M. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data. Ann Am Thorac Soc. 2016 07; 13(7):1067-75. PMID: 27070274.
    Citations: 5     Fields:    Translation:Humans
  117. Simon JA, Laliberté F, Duh MS, Pilon D, Kahler KH, Nyirady J, Davis PJ, Lefebvre P. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy. Menopause. 2016 06; 23(6):600-10. PMID: 26953655.
    Citations: 8     Fields:    Translation:Humans
  118. Lefebvre P, Pilon D, Robitaille MN, Lafeuille MH, Chow W, Pfeifer M, Duh MS. Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study. Curr Med Res Opin. 2016 06; 32(6):1151-9. PMID: 27115475.
    Citations: 4     Fields:    Translation:Humans
  119. Calnan M, Krishnarajah G, Duh MS, Haider BA, Yermakov S, Davis M, Yan S. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance. Hum Vaccin Immunother. 2016 05 03; 12(5):1235-43. PMID: 26900728.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  120. Quinlan SC, Cheng WY, Ishihara L, Irizarry MC, Holick CN, Duh MS. Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):413-21. PMID: 26889887.
    Citations:    Fields:    Translation:Humans
  121. Xiao Y, Muser E, Fu DJ, Lafeuille MH, Pilon D, Emond B, Wu A, Duh MS, Lefebvre P. Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics. Curr Med Res Opin. 2016; 32(4):759-69. PMID: 26750639.
    Citations: 3     Fields:    Translation:Humans
  122. Krishnarajah G, Duh MS, Korves C, Demissie K. Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States. PLoS One. 2016; 11(1):e0145977. PMID: 26751375.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  123. Vekeman F, Sasane M, Cheng WY, Ramanakumar AV, Fortier J, Qiu Y, Duh MS, Paley C, Adams-Graves P. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia. J Med Econ. 2016; 19(3):292-303. PMID: 26618853.
    Citations: 12     Fields:    Translation:Humans
  124. Kruse G, Wong BJ, Duh MS, Lefebvre P, Lafeuille MH, Fastenau JM. Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. Pharmacoeconomics. 2015 Oct; 33(10):1049-67. PMID: 25963579.
    Citations: 1     Fields:    Translation:Humans
  125. Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Dalal AA. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015 Dec; 136(6):1488-1495. PMID: 26414880.
    Citations: 48     Fields:    Translation:Humans
  126. Vekeman F, Gauthier-Loiselle M, Faust E, Lefebvre P, Lahoz R, Duh MS, Sacco P. Patient and Caregiver Burden Associated With Fragile X Syndrome in the United States. Am J Intellect Dev Disabil. 2015 Sep; 120(5):444-59. PMID: 26322391.
    Citations: 3     Fields:    Translation:Humans
  127. Vekeman F, Magestro M, Karner P, Duh MS, Nichols T, van Waalwijk van Doorn-Khosrovani SB, Zonnenberg BA. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ. 2015; 18(12):1060-70. PMID: 26201433.
    Citations: 16     Fields:    Translation:Humans
  128. Xiao Y, Muser E, Lafeuille MH, Pesa J, Fastenau J, Duh MS, Lefebvre P. Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients. J Comp Eff Res. 2015 Nov; 4(6):579-92. PMID: 26168935.
    Citations: 7     Fields:    Translation:Humans
  129. Toy EL, Vekeman F, Lewis MC, Oglesby AK, Duh MS. Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting. Curr Med Res Opin. 2015 Aug; 31(8):1561-72. PMID: 26086578.
    Citations: 11     Fields:    Translation:Humans
  130. Yermakov S, Davis M, Calnan M, Fay M, Cox-Buckley B, Sarda S, Duh MS, Iyer R. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis. J Med Econ. 2015; 18(9):711-20. PMID: 25903661.
    Citations: 10     Fields:    Translation:Humans
  131. Blinder MA, Duh MS, Sasane M, Trahey A, Paley C, Vekeman F. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease. J Emerg Med. 2015 Oct; 49(4):513-522.e1. PMID: 25910824.
    Citations: 16     Fields:    Translation:Humans
  132. Vekeman F, Cheng WY, Sasane M, Huynh L, Duh MS, Paley C, Mesa RA. Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy. Leuk Lymphoma. 2015; 56(10):2803-11. PMID: 25676036.
    Citations: 2     Fields:    Translation:Humans
  133. Wagner MJ, Amodu LI, Duh MS, Korves C, Solleza F, Manson SC, Diaz J, Neary MP, Demetri GD. A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments. BMC Cancer. 2015 Mar 25; 15:175. PMID: 25885530.
    Citations: 11     Fields:    Translation:Humans
  134. Gradman AH, Vekeman F, Eldar-Lissai A, Trahey A, Duh MS, Ong SH. Response to comment on "is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database". J Card Fail. 2015 May; 21(5):435. PMID: 25796428.
    Citations:    Fields:    Translation:Humans
  135. Sarrel P, Portman D, Lefebvre P, Lafeuille MH, Grittner AM, Fortier J, Gravel J, Duh MS, Aupperle PM. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015 Mar; 22(3):260-6. PMID: 25714236.
    Citations: 20     Fields:    Translation:Humans
  136. Lafeuille MH, Grittner AM, Fortier J, Muser E, Fasteneau J, Duh MS, Lefebvre P. Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics. Am J Health Syst Pharm. 2015 Mar 01; 72(5):378-89. PMID: 25694413.
    Citations: 13     Fields:    Translation:Humans
  137. Yenikomshian MA, Guignard AP, Haguinet F, LaCasce AS, Skarin AT, Trahey A, Karner P, Duh MS. The epidemiology of herpes zoster and its complications in Medicare cancer patients. BMC Infect Dis. 2015 Feb 27; 15:106. PMID: 25888128.
    Citations: 11     Fields:    Translation:HumansCells
  138. Jordan L, Adams-Graves P, Kanter-Washko J, Oneal PA, Sasane M, Vekeman F, Bieri C, Magestro M, Marcellari A, Duh MS. Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapy. Curr Med Res Opin. 2015 Mar; 31(3):513-23. PMID: 25495135.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  139. Vekeman F, Cloutier M, Yermakov S, Amonkar MM, Arondekar B, Duh MS. Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population. Melanoma Res. 2014 Dec; 24(6):602-10. PMID: 24926818.
    Citations: 2     Fields:    Translation:Humans
  140. Lafeuille MH, Grittner AM, Gravel J, Bailey RA, Martin S, Garber L, Duh MS, Lefebvre P. Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control. J Med Econ. 2015 Feb; 18(2):113-25. PMID: 25350645.
    Citations: 1     Fields:    Translation:Humans
  141. Ayyagari R, Vekeman F, Lefebvre P, Ong SH, Faust E, Trahey A, Machnicki G, Duh MS. Pulse pressure and stroke risk: development and validation of a new stroke risk model. Curr Med Res Opin. 2014 Dec; 30(12):2453-60. PMID: 25265131.
    Citations: 4     Fields:    Translation:Humans
  142. Gradman AH, Vekeman F, Eldar-Lissai A, Trahey A, Ong SH, Duh MS. Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database. J Card Fail. 2014 Nov; 20(11):853-63. PMID: 25152497.
    Citations:    Fields:    Translation:Humans
  143. Strosberg JR, Benson AB, Huynh L, Duh MS, Goldman J, Sahai V, Rademaker AW, Kulke MH. Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study. Oncologist. 2014 Sep; 19(9):930-6. PMID: 25096997.
    Citations: 33     Fields:    Translation:HumansCTClinical Trials
  144. Porta C, Levy A, Hawkins R, Castellano D, Bellmunt J, Nathan P, McDermott R, Wagstaff J, Donnellan P, McCaffrey J, Vekeman F, Neary MP, Diaz J, Mehmud F, Duh MS. Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries. Cancer Med. 2014 Dec; 3(6):1517-26. PMID: 25045157.
    Citations: 20     Fields:    Translation:Humans
  145. Knopf KB, Duh MS, Lafeuille MH, Gravel J, Lefebvre P, Niculescu L, Ba-Mancini A, Ma E, Shi H, Comenzo RL. Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma. Clin Lymphoma Myeloma Leuk. 2014 Oct; 14(5):380-8. PMID: 25023616.
    Citations: 17     Fields:    Translation:Humans
  146. Lafeuille MH, Dean J, Carter V, Duh MS, Fastenau J, Dirani R, Lefebvre P. Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia. Curr Med Res Opin. 2014 Aug; 30(8):1643-55. PMID: 24730586.
    Citations: 22     Fields:    Translation:Humans
  147. Athanasiou Y, Zavros M, Arsali M, Papazachariou L, Demosthenous P, Savva I, Voskarides K, Deltas C, Pierides A, Feriozzi S, Perrin A, West M, Nicholls K, Sunder-Plassmann G, Torras J, Neumann P, Cybulla M, Cofiell R, Kukreja A, Bedard K, Yan Y, Mickle A, Ogawa M, Bedrosian C, Faas S, Mészáros K, Pruess L, Gondan M, Ritz E, Schaefer F, Testa A, Spoto B, Leonardis D, Sanguedolce MC, Pisano A, Parlongo MR, Tripepi G, Mallamaci F, Zoccali C, Trujillano D, Bullich G, Ballarin J, Torra R, Estivill X, Ars E, Kleber ME, Delgado G, Grammer TB, Silbernagel G, Kraemer BK, Maerz W, Riccio E, Pisani A, Abdalla AA, Malone AF, Winn MP, Goodship T, Cronin C, Conlon PJ, Casserly LF, Nishio S, Sakuhara Y, Matsuoka N, Yamamoto J, Nakazawa D, Nakagakaki T, Abo D, Shibazaki S, Atsumi T, Mazzinghi B, Giglio S, Provenzano A, Becherucci F, Sansavini G, Ravaglia F, Roperto RM, Murer L, Lasagni L, Materassi M, Romagnani P, Schmidts M, Christou S, Cortes C, McInerney-Leo A, Kayserili H, Zankl A, Peter S, Duncan E, Wicking C, Beales PL, Mitchison H, Magestro M, Vekeman F, Nichols T, Karner P, Duh MS, Srivastava B, Van Doorn-Khosrovani SB, Zonnenberg BA, Musetti C, Quaglia M, Ghiggeri GM, Fogazzi GB, Settanni F, Boldorini RL, Lazzarich E, Airoldi A, Izzo C, Giordano M, Stratta P, Garrido P, Fernandes JC, Ribeiro S, Belo L, Costa EC, Reis F, Santos-Silva A, Youssef DM, Alshal AS, Salah K, Rashed AE, Kingswood JC, Jozwiak S, Belousova E, Frost M, Kuperman R, Bebin EM, Korf B, Flamini JR, Kohrman MH, Sparagana S, Wu JY, Berkowitz N, Miao S, Segal S, Ridolfi A, Bissler JJ, Franz DN, Oud MM, Van Bon BW, Bongers EM, Hoischen A, Marcelis CL, De Leeuw N, Mol SJ, Mortier G, Knoers NV, Brunner HG, Roepman R, Arts HH, Van Eerde AM, Van Der Zwaag B, Lilien MR, Renkema KY, De Borst MH, Van Haaften G, Giles RH, Navis GJ, Knoers NV, Lu KC, Su SL, Gigante M, Santangelo L, Diella S, Argentiero L, Cianciotta F, Martino M, Ranieri E, Grandaliano G, Giordano M, Gesualdo L, Fernandes J, Ribeiro S, Garrido P, Sereno J, Costa E, Reis F, Santos-Silva A, Chub O, Aires I, Polidori D, Santos AR, Brito Costa A, Simoes C, Rueff J, Nolasco F, Calado J, Van Der Tol L, Biegstraaten M, Florquin S, Vogt L, Van Den Bergh Weerman MA, Hollak CE, Hughes DA, Lachmann RH, Oliveira JP, Ortiz A, Svarstad E, Terryn W, Tøndel C, Waldek S, Wanner C, West ML, Linthorst GE, Kaesler N, Brandenburg V, Theuwissen E, Vermeer C, Floege J, Schlieper G, Krüger T, Xydakis D, Goulielmos G, Antonaki E, Stylianoy K, Sfakianaki M, Papadogiannakis A, Dafnis E, Mdimegh S, Ben Hadj Mbarek-Fredj I, Moussa A, Omezzine A, Zellama D, Mabrouk S, Zouari N, Hassayoun S, Chemli J, Achour A, Bouslama A, Abroug S, Spoto B, Leonardis D, Politi C, Pisano A, Cutrupi S, Testa A, Parlongo RM, D'Arrigo G, Tripepi G, Mallamaci F, Zoccali C, Mdimegh S, Ben Hadj Mbarek-Fredj I, Moussa A, Omezzine A, Mabrouk S, Zouari N, Hassayoun S, Chemli J, Zellama D, Achour A, Bouslama A, Abroug S, Hohenstein-Scheibenecker K, Schmidt A, Stylianou KG, Kyriazis J, Androvitsanea A, Tzanakakis M, Maragkaki E, Petrakis J, Stratakis S, Poulidaki R, Vardaki E, Petra C, Statigis S, Perakis K, Daphnis E, Cybulla M, West M, Nicholls K, Torras J, Neumann P, Sunder-Plassmann G, Feriozzi S, Metzinger-Le Meuth V, Taïbi F, M'Baya-Moutoula E, Louvet L, Massy Z, Metzinger L, Mani LY, Sidler D, Vogt B, Nikolskaya N, Cox JA, Kingswood JC, Smirnov A, Zarayski M, Kayukov I, Karunnaya H, Sipovski V, Kukoleva L, Dobronravov V. Genetic diseases and molecular genetics. Nephrol Dial Transplant. 2014 May; 29 Suppl 3:iii339-iii350. PMID: 24849976.
    Citations:    
  148. Victorson D, Carlozzi NE, Frank S, Beaumont JL, Cheng W, Gorin B, Duh MS, Samuelson D, Tulsky D, Gutierrez S, Nowinski CJ, Mueller A, Shen V, Sung V. Identifying Motor, Emotional-Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives. Tremor Other Hyperkinet Mov (N Y). 2014; 4:224. PMID: 24757585.
    Citations: 9     Fields:    
  149. Carlozzi NE, Victorson D, Sung V, Beaumont JL, Cheng W, Gorin B, Duh MS, Samuelson D, Tulsky D, Gutierrez S, Nowinski CJ, Mueller A, Shen V, Frank S. HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington's Disease. Tremor Other Hyperkinet Mov (N Y). 2014; 4:223. PMID: 24761312.
    Citations: 9     Fields:    
  150. Oglesby A, Korves C, Laliberté F, Dennis G, Rao S, Suthoff ED, Wei R, Duh MS. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes. Appl Health Econ Health Policy. 2014 Apr; 12(2):179-90. PMID: 24573911.
    Citations: 22     Fields:    Translation:Humans
  151. Lafeuille MH, Dean J, Fastenau J, Panish J, Olson W, Markowitz M, Duh MS, Lefebvre P. Burden of schizophrenia on selected comorbidity costs. Expert Rev Pharmacoecon Outcomes Res. 2014 Apr; 14(2):259-67. PMID: 24593801.
    Citations: 7     Fields:    Translation:Humans
  152. Laliberté F, Lefebvre P, Law A, Duh MS, Pocoski J, Lynen R, Darney P. Medicaid spending on contraceptive coverage and pregnancy-related care. Reprod Health. 2014 Mar 03; 11(1):20. PMID: 24581033.
    Citations: 2     Fields:    Translation:Humans
  153. Duh MS, Hackshaw MD, Ivanova JI, Kruse G, Miller LA, Lefebvre P, Karner P, Wong B. Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population. Sarcoma. 2013; 2013:947413. PMID: 24453570.
    Citations: 2     
  154. Oh WK, McDermott D, Porta C, Levy A, Elaidi R, Scotte F, Hawkins R, Castellano D, Bellmunt J, Rha SY, Sun JM, Nathan P, Feinberg BA, Scott J, McDermott R, Ahn JH, Wagstaff J, Chang YH, Ou YC, Donnellan P, Huang CY, McCaffrey J, Chiang PH, Chuang CK, Korves C, Neary MP, Diaz JR, Mehmud F, Duh MS. Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review. Int J Oncol. 2014 Jan; 44(1):5-16. PMID: 24247547.
    Citations: 12     Fields:    Translation:Humans
  155. Chu DS, Johnson SJ, Mallya UG, Davis MR, Sorg RA, Duh MS. Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA. J Ophthalmic Inflamm Infect. 2013 Nov 06; 3(1):64. PMID: 24195808.
    Citations: 13     
  156. Huynh L, McCoy M, Law A, Tran KN, Knuth S, Lefebvre P, Sullivan S, Duh MS. Systematic literature review of the costs of pregnancy in the US. Pharmacoeconomics. 2013 Nov; 31(11):1005-30. PMID: 24158771.
    Citations: 13     Fields:    Translation:Humans
  157. Lefebvre P, Laliberté F, Nutescu EA, Duh MS, LaMori J, Bookhart BK, Olson WH, Dea K, Hossou Y, Schein J, Kaatz S. All-cause and disease-related health care costs associated with recurrent venous thromboembolism. Thromb Haemost. 2013 Dec; 110(6):1288-97. PMID: 24085327.
    Citations: 5     Fields:    Translation:Humans
  158. Lafeuille MH, Gravel J, Lefebvre P, Fastenau J, Muser E, Doshi D, Duh MS. Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics. J Med Econ. 2013 Nov; 16(11):1290-9. PMID: 24006903.
    Citations: 12     Fields:    Translation:Humans
  159. Lafeuille MH, Laliberté-Auger F, Lefebvre P, Frois C, Fastenau J, Duh MS. Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis. BMC Psychiatry. 2013 Sep 10; 13:221. PMID: 24016390.
    Citations: 22     Fields:    Translation:Humans
  160. Virdi NS, Lefebvre P, Parisé H, Duh MS, Pilon D, Laliberté F, Sundaresan D, Garber L, Dirani R. Association of self-monitoring of blood glucose use on glycated hemoglobin and weight in newly diagnosed, insulin-naïve adult patients with type 2 diabetes. J Diabetes Sci Technol. 2013 Sep 01; 7(5):1229-42. PMID: 24124950.
    Citations: 3     Fields:    Translation:Humans
  161. Nakabayashi M, Hayes J, Taplin ME, Lefebvre P, Lafeuille MH, Pomerantz M, Sweeney C, Duh MS, Kantoff PW. Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. Cancer. 2013 Aug 15; 119(16):2990-8. PMID: 23719969.
    Citations: 8     Fields:    Translation:Humans
  162. Parisé H, Laliberté F, Lefebvre P, Duh MS, Kim E, Agashivala N, Abouzaid S, Weinstock-Guttman B. Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers. J Neurol Sci. 2013 Jul 15; 330(1-2):71-7. PMID: 23647840.
    Citations: 15     Fields:    Translation:Humans
  163. Castellano D, Duh MS, Korves C, Suthoff ED, Neary M, Hernández Pastor LJ, Bellmunt J. Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain. Expert Opin Drug Saf. 2013 Jul; 12(4):455-63. PMID: 23510293.
    Citations: 1     Fields:    Translation:Humans
  164. Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatr Blood Cancer. 2013 May; 60(5):828-35. PMID: 23335275.
    Citations: 28     Fields:    Translation:Humans
  165. Garrison LP, Wang ST, Huang H, Ba-Mancini A, Shi H, Chen K, Korves C, Dhawan R, Cakana A, van de Velde H, Corzo D, Duh MS. The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatment. Oncologist. 2013; 18(1):27-36. PMID: 23299777.
    Citations: 26     Fields:    Translation:Humans
  166. Ivanova JI, Mytelka DS, Duh MS, Birnbaum HG, Cummings AK, San Roman AM, Price GL, Swindle RW. Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data. Patient. 2013; 6(3):189-200. PMID: 23828691.
    Citations: 2     Fields:    Translation:Humans
  167. Laliberté F, Bookhart BK, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS. Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient. 2013; 6(3):213-24. PMID: 23857628.
    Citations: 26     Fields:    Translation:Humans
  168. Gradman AH, Parisé H, Lefebvre P, Falvey H, Lafeuille MH, Duh MS. Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study. Hypertension. 2013 Feb; 61(2):309-18. PMID: 23184383.
    Citations: 33     Fields: